Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs

The development of multidrug resistance (MDR) in cancer patients, which is often associated with the overexpression of ABCB1 (MDR1, P-glycoprotein) in cancer cells, remains a significant problem in cancer chemotherapy. ABCB1 is one of the major adenosine triphosphate (ATP)-binding cassette (ABC) tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chung-Pu, Hung, Tai-Ho, Hsiao, Sung-Han, Huang, Yang-Hui, Hung, Lang-Cheng, Yu, Yi-Jou, Chang, Yu-Tzu, Wang, Shun-Ping, Wu, Yu-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352346/
https://www.ncbi.nlm.nih.gov/pubmed/32466597
http://dx.doi.org/10.3390/cancers12061366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352346/
https://www.ncbi.nlm.nih.gov/pubmed/32466597
http://dx.doi.org/10.3390/cancers12061366

Ejemplares similares